Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Portfolio

Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

CropIn Technology

CropIn is a Bangalore-based company developing software-as-a-service for agriculture enterprises to drive efficiency in farming operations. The primary use-case is for agriculture businesses (food processors, contract farming companies) whose field agents use CropIn’s SmartFarm mobile app to periodically track farm Read More

Press Release
News Story
CureVac Logo

CureVac

The foundation invested in CureVac to accelerate vaccine technology development, getting life-saving and low-cost vaccines to people who need them most.

Press Release
News Story
DKT Logo

DKT

Many people across the world lack access to safe and affordable contraceptives. To address this need, we provided a low-interest loan to help DKT International increase sustainable access to vital reproductive health products in developing countries.

Press Release

Eastside Prepatory School

Eastside Preparatory School is a college-preparatory school located in Kirkland, Washington. The foundation provided a loan to support an expansion of the organization’s campus. Investment Date: February 2017

Enko Chem

Enko Chem is an early stage agricultural life sciences company that is looking to apply DNA encoded library technology to identify and develop new, safer chemical compounds that protect crops from pests and disease. The foundation invested in the Company Read More

Press Release

Evolve BioSystems

Evolve BioSystems is an infant microbiome company dedicated to developing the next generation of products to establish, restore and maintain a healthy gut microbiome. The foundation is working with Evolve to further develop and apply its lead probiotic, Evivo, to Read More

Press Release
News Story

Gavi / Serum

The foundation has partnered with Gavi and the Serum Institute of India (“SII”) to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for low- and middle-income countries. The collaboration was expanded in August 2020 Read More

Press Release
Genocea Logo

Genocea

Genocea harnesses the power of T cells to discover life-changing vaccines and immunotherapies. The foundation partnered with the team to identify antigens for future malaria vaccines as T cell response is critical during the liver-stage of disease.

Press Release
Case Study
GHIF Logo

Global Health Investment Fund (GHIF)

The foundation sponsored the creation of GHIF as a social impact investment fund to support the development of drugs, vaccines, and diagnostics for diseases that specifically burden low- and middle-income populations.

Press Release
AGHF Logo

Growth Markets Health Fund

The Abraaj Growth Markets Health Fund is an investment fund designed to address poor health outcomes caused by inefficient healthcare systems in Africa and Asia.

Halodoc

Halodoc is an online-to-offline (“O2O”) health delivery marketplace launched in 2016 and based in Jakarta, Indonesia. The Company aims to improve accessibility, affordability, and quality of healthcare for at least 100 million Indonesians by systemically addressing inefficiencies and resource misallocation Read More

Press Release
News Story

Hester Biosciences Africa Limited

Hester Biosciences Africa Limited (“Hester Africa”), a newly-formed Tanzanian company and a wholly-owned subsidiary of Hester Biosciences Limited (“Hester”), is building an animal vaccine manufacturing facility near Dar es Salaam. Hester has a 20-year track record manufacturing and distributing livestock Read More

immunocore logo

Immunocore

Immunocore develops innovative biological therapeutics that exploit the power of the body’s own immune system to find and kill diseased cells. The foundation partnered with the company to expand its focus into infectious disease.

Press Release
Intarcia Logo

Intarcia

The foundation invested in Intarcia to help prevent the spread of HIV in Sub-Saharan Africa and other areas where the HIV epidemic is most severe.

Press Release
News Story
JUST Logo

Just Biotherapeutics

Just Biotherapeutics is developing an integrated technology platform to accelerate the development and manufacturing of high-quality biologics at a significantly lower cost, to broaden global biologic access.

KIPP Logo

KIPP Houston

KIPP Houston is a Charter Management Organization (CMO) and a top-ranked school system for low-income students. The investment provided affordable facility financing to high-performing CMOs.

Press Release
kymab logo

Kymab

Kymab has developed a proprietary mouse platform which contains the full range of human antibodies, leading to faster discovery of prophylactic and therapeutic monoclonal antibodies.

Press Release
Case Study

Lilly mAb

The foundation partnered with Eli Lilly and Company to facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19 for low- and middle-income countries as part of the COVID-19 Therapeutics Accelerator. The COVID-19 antibodies Read More

Press Release
Liquidia Logo

Liquidia

The foundation invested in Liquidia to support the application of Liquidia’s PRINT® technology to vaccine development for infectious diseases.

Lodo Therapeutics Logo

Lodo Therapeutics

Lodo Therapeutics is creating a best-in-class natural product drug discovery platform for the discovery, biosynthesis, and characterization of new, genetically encoded small molecules.

LumiraDx

LumiraDx develops point-of-care diagnostics solutions on a portable, cloud-connected reader using finger-prick blood samples tested on disposable, microfluidic strips. The company is working to achieve lab-quality performance and health-IT integration at point-of–care settings globally. The foundation invested in the company Read More

Lyndra Therapeutics

Lyndra Therapeutics is developing an orally administered dosage form designed to deliver sustained, steady-state release of one or more drugs for up to a week or longer while temporarily residing in the stomach. The foundation invested in the company to Read More

Press Release
M-Kopa Logo

M-KOPA

M-KOPA is a Nairobi-based, off-grid solar energy company, which makes residential power systems affordable and accessible to low-income, off-grid customers through a mobile payment-based lease-to-own model.

Press Release
Case Study
Medical Credit Fund Logo

Medical Credit Fund (MCF)

The Medical Credit Fund provides loans and technical assistance to small primary care clinics in Africa. Through the loan fund, MCF expanded its lending and technical assistance across Ghana, Nigeria, Kenya, and Tanzania.

Press Release
Merck Logo

Merck

The foundation partnered with private and public organizations make Implanon NXT®, a single rod, long-acting, reversible contraceptive implant, available in the world’s poorest countries at a more than 50 percent price reduction.

Press Release
Case Study
Mylan Logo

Mylan Dolutegravir

Mylan Laboratories, along with Aurobindo Pharma, received support from the foundation to expand the distribution of a single-pill HIV treatment containing dolutegravir to low- and middle-income populations at a low price.

Press Release
News Story
Orasure Logo

OraSure

The foundation invested in OraSure to secure a reduced price for the saliva-based HIV self-test OraQuick.

Press Release
News Story
Owl Ventures Logo

Owl Ventures

Owl Ventures is a venture investment fund that leads Series A/B investments in US K-12 education technology companies.

PAHO and WHO logos

PAHO

The Pan American Health Organization (PAHO) is an international public health agency working to improve health and living standards in America.

Pfizer Logo

Pfizer

The foundation invested in Pfizer to expand access to the pharmaceutical company’s all-in-one injectable contraceptive, Sayana, giving women in the developing world an affordable option.